SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/E3D06FDA8FD28AE2FD7838D946C94A22BF40DAB67B1EBD15B8DBECD39D02568C9802FC19BBDF043E52A43A36B1790F47>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/E3D06FDA8FD28AE2FD7838D946C94A22BF40DAB67B1EBD15B8DBECD39D02568C9802FC19BBDF043E52A43A36B1790F47
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E3D06FDA8FD28AE2FD7838D946C94A22BF40DAB67B1EBD15B8DBECD39D02568C9802FC19BBDF043E52A43A36B1790F47
http://www.w3.org/2000/01/rdf-schema#comment
"These parallel in vivo and in vitro data suggest that HLA-B57 confers its advantage primarily by driving and maintaining a fitness-attenuating mutation in p24-Gag."
xsd:string
http://purl.uniprot.org/uniprot/#_33B9A39E1AE424F67333A8EA08F6253FD3306B1A7ED5B1374A3C1E2BA231DBE3D8382909AFD2980D11893EFD3C7F70CB
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/E3D06FDA8FD28AE2FD7838D946C94A22BF40DAB67B1EBD15B8DBECD39D02568C9802FC19BBDF043E52A43A36B1790F47
http://purl.uniprot.org/uniprot/B0BKZ6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E3D06FDA8FD28AE2FD7838D946C94A22BF40DAB67B1EBD15B8DBECD39D02568C9802FC19BBDF043E52A43A36B1790F47
http://purl.uniprot.org/uniprot/#_B0BKZ6-mappedCitation-19515764
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/E3D06FDA8FD28AE2FD7838D946C94A22BF40DAB67B1EBD15B8DBECD39D02568C9802FC19BBDF043E52A43A36B1790F47